Noble treatment for PTSD

Xenon may one day become a promising new treatment for post-traumatic stress disorder (PTSD) following an investigation by researchers at Harvard Medical School, US.

Edward Meloni and colleagues exposed a group of 94 rats to frightening stimuli. Rats who were administered xenon gas during a critical period of time known as the reconsolidation window – when reactivated memories become temporarily susceptible to modification – showed less fear than those who were not.

Xenon achieved this effect by inhibiting glutamatergic NMDA receptors in the brain, involved in memory reconsolidation. Exposure to xenon gas at just the right time interrupts the reconsolidation process and prevents the recollection of powerful emotions such as fear.

If similar effects are seen in humans, xenon gas could be used to help individuals suffering from PTSD.  This treatment is particularly exciting because xenon has already been shown to be safe in humans, thanks to its use as an anaesthetic and diagnostic imaging agent.

Related Content

Of mice and men

30 March 2011 Premium contentFeature

news image

2009 marked the first year that more genetically modified animals were used in UK scientific procedures than animals deemed '...

Bacterium altered to suppress hunger faces long road to clinic

24 March 2015 Research

news image

Engineered microbes produce anti-obesity molecule in mice, but moving to humans poses challenges

Most Commented

Chlorinated compounds form in tea and coffee

24 November 2015 Research

news image

Treated water reacts with organics to form disinfection byproducts

Brazilian mine disaster releases dangerous metals

21 November 2015 News and Analysis

news image

Irreversible negative human health and environmental effects could result from Brazilian mine’s dam collapse